Population Analysis of Pharmacogenetic Polymorphisms Related to Acute Lymphoblastic Leukemia Drug Treatment
This study aimed to evaluate in the Brazilian population, the genotypes and population frequencies of pharmacogenetic polymorphisms involved in the response to drugs used in treatment of acute lymphoblastic leukemia (ALL), and to compare the data with data from the HapMap populations. There was sign...
Main Authors: | Marcela A. Chiabai, Tulio C. L. Lins, Robert Pogue, Rinaldo W. Pereira |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.3233/DMA-2011-0884 |
Similar Items
-
Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic Leukemia
by: Maamari D, et al.
Published: (2020-08-01) -
Pharmacogenetic analysis of pediatric patients with acute lymphoblastic leukemia: a possible association between survival rate and ITPA polymorphism.
by: Hyery Kim, et al.
Published: (2012-01-01) -
Pharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia.
by: Elixabet López-López, et al.
Published: (2014-01-01) -
Screening of Novel Pharmacogenetic Candidates for Mercaptopurine-Induced Toxicity in Patients With Acute Lymphoblastic Leukemia
by: Minyuan Cao, et al.
Published: (2020-03-01) -
Importance of pharmacogenetic markers in the methylenetetrahydrofolate reductase gene during methotrexate treatment in pediatric patients with acute lymphoblastic leukemia
by: Lazić Jelena, et al.
Published: (2017-01-01)